PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CLOV vs. LUMN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


CLOVLUMN
YTD Return223.50%371.58%
1Y Return201.96%525.36%
3Y Return (Ann)-25.93%-12.69%
Sharpe Ratio2.424.24
Sortino Ratio3.214.93
Omega Ratio1.381.62
Calmar Ratio2.115.92
Martin Ratio12.5325.00
Ulcer Index16.36%22.55%
Daily Std Dev84.61%133.07%
Max Drawdown-97.19%-95.26%
Current Drawdown-86.09%-58.25%

Fundamentals


CLOVLUMN
Market Cap$1.63B$9.37B
EPS-$0.19-$2.17
Total Revenue (TTM)$1.54B$13.30B
Gross Profit (TTM)$522.63M$3.61B
EBITDA (TTM)-$68.65M$3.74B

Correlation

-0.50.00.51.00.2

The correlation between CLOV and LUMN is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

CLOV vs. LUMN - Performance Comparison

In the year-to-date period, CLOV achieves a 223.50% return, which is significantly lower than LUMN's 371.58% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%200.00%400.00%600.00%JuneJulyAugustSeptemberOctoberNovember
229.69%
558.98%
CLOV
LUMN

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CLOV vs. LUMN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Lumen Technologies, Inc. (LUMN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CLOV
Sharpe ratio
The chart of Sharpe ratio for CLOV, currently valued at 2.42, compared to the broader market-4.00-2.000.002.004.002.42
Sortino ratio
The chart of Sortino ratio for CLOV, currently valued at 3.21, compared to the broader market-4.00-2.000.002.004.006.003.21
Omega ratio
The chart of Omega ratio for CLOV, currently valued at 1.38, compared to the broader market0.501.001.502.001.38
Calmar ratio
The chart of Calmar ratio for CLOV, currently valued at 2.11, compared to the broader market0.002.004.006.002.11
Martin ratio
The chart of Martin ratio for CLOV, currently valued at 12.53, compared to the broader market0.0010.0020.0030.0012.53
LUMN
Sharpe ratio
The chart of Sharpe ratio for LUMN, currently valued at 4.24, compared to the broader market-4.00-2.000.002.004.004.24
Sortino ratio
The chart of Sortino ratio for LUMN, currently valued at 4.93, compared to the broader market-4.00-2.000.002.004.006.004.93
Omega ratio
The chart of Omega ratio for LUMN, currently valued at 1.62, compared to the broader market0.501.001.502.001.62
Calmar ratio
The chart of Calmar ratio for LUMN, currently valued at 6.08, compared to the broader market0.002.004.006.006.08
Martin ratio
The chart of Martin ratio for LUMN, currently valued at 25.00, compared to the broader market0.0010.0020.0030.0025.00

CLOV vs. LUMN - Sharpe Ratio Comparison

The current CLOV Sharpe Ratio is 2.42, which is lower than the LUMN Sharpe Ratio of 4.24. The chart below compares the historical Sharpe Ratios of CLOV and LUMN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.006.00JuneJulyAugustSeptemberOctoberNovember
2.42
4.24
CLOV
LUMN

Dividends

CLOV vs. LUMN - Dividend Comparison

Neither CLOV nor LUMN has paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
CLOV
Clover Health Investments, Corp.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LUMN
Lumen Technologies, Inc.
0.00%0.00%14.37%7.97%10.26%7.57%14.26%12.95%9.08%8.59%5.46%6.78%

Drawdowns

CLOV vs. LUMN - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.19%, roughly equal to the maximum LUMN drawdown of -95.26%. Use the drawdown chart below to compare losses from any high point for CLOV and LUMN. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%JuneJulyAugustSeptemberOctoberNovember
-86.09%
-37.14%
CLOV
LUMN

Volatility

CLOV vs. LUMN - Volatility Comparison

The current volatility for Clover Health Investments, Corp. (CLOV) is 20.62%, while Lumen Technologies, Inc. (LUMN) has a volatility of 27.14%. This indicates that CLOV experiences smaller price fluctuations and is considered to be less risky than LUMN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


20.00%40.00%60.00%80.00%JuneJulyAugustSeptemberOctoberNovember
20.62%
27.14%
CLOV
LUMN

Financials

CLOV vs. LUMN - Financials Comparison

This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Lumen Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items